Lewis B. Silverman

Columbia University Irving Medical Center US

0009-0007-7275-7650

487

Publications

28,240

Citations

H-Index

195

i10-Index

1.38

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Activating Mutations of <i>NOTCH1</i> in Human T Cell Acute Lymphoblastic Leukemia

Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee, John P. Morris, Lewis B. Silverman +4 more

Science 2004

2,707

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

Scott A. Armstrong, Jane Staunton, Lewis B. Silverman, Rob Pieters, Monique L. den Boer +5 more

Nature Genetics 2001

1,716

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Ching‐Hon Pui, Jun J. Yang, Stephen P. Hunger, Rob Pieters, Martin Schrappe +15 more

Journal of Clinical Oncology 2015

983

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element OA

Marc R. Mansour, Brian J. Abraham, Lars Anders, Alla Berezovskaya, Alejandro Gutiérrez +10 more

Science 2014

802

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Rob Pieters, Martin Schrappe, Paola De Lorenzo, Ian Hann, Giulio Rossi +16 more

The Lancet 2007

646

Publications

487 total

Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen OA

S. Shimony, Hari S. Raman, Yael Flamand, Julia H. Keating, J. Paolino - Blood Cancer Journal, 2024

Cited by 6 Semantic Scholar

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL): Post hoc analysis of adverse events of interest from AALL1931.

Etsuko Aoki, L. Maese, M. Loh, Shirali Agarwal, Vijayalakshmi Chandrasekaran - Journal of Clinical Oncology, 2024

Cited by 0 Semantic Scholar

Abstract B025: Genome-wide study identifies novel genes associated with bone toxicities among children with acute lymphoblastic leukemia

Qianqian Zhu, Ram Mambiar, E. Schultz, Xinyu Gao, Shuyi Liang - Cancer Research, 2024

Cited by 0 Semantic Scholar

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study OA

L. Maese, M. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki - Blood, 2023

Cited by 3 Semantic Scholar

Oral Chemotherapy Adherence in Pediatric Acute Lymphoblastic Leukemia (ALL): A Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 16-001 OA

Justine M. Kahn, H. Patel, Julia H. Keating, Yael Flamand, Victoria B. Koch - Blood, 2023

Cited by 0 Semantic Scholar

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) OA

L. Maese, M. Loh, Mi Rim Choi, Yali Liang, Etsuko Aoki - Blood, 2023

Cited by 0 Semantic Scholar

Updated Results on a Multicenter Phase II Study of a Dose Intensified Pediatric Regimen in Adults with Acute Lymphoblastic Leukemia: The 06-254 DFCI ALL Consortium Trial OA

Yannis K. Valtis, Yael Flamand, S. Shimony, A. Place, L. Silverman - Blood, 2023

Cited by 1 Semantic Scholar

PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION OA

L. Gore, M. Loh, C. Pui, Y. Matloub, M. J. Hanley - HemaSphere, 2022

Cited by 0 Semantic Scholar

ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or With T315I Mutation.

Lia Gore, Mignon Loh, C. Pui, Y. Matloub, M. J. Hanley - Clinical Lymphoma, Myeloma & Leukemia, 2022

Cited by 0 Semantic Scholar

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Ching‐Hon Pui, Jun J. Yang, Stephen P. Hunger, Rob Pieters, Martin Schrappe et al. - Journal of Clinical Oncology, 2015

Cited by 983 OpenAlex

Research Topics

Acute Lymphoblastic Leukemia research (375) Childhood Cancer Survivors' Quality of Life (196) Acute Myeloid Leukemia Research (95) Chronic Lymphocytic Leukemia Research (49) Chronic Myeloid Leukemia Treatments (49)

Frequent Co-Authors

Stephen E. Sallan

9 joint publications

Rob Pieters

5 joint publications

Stephen P. Hunger

4 joint publications

Martin Schrappe

4 joint publications

André Baruchel

4 joint publications

A. Thomas Look

3 joint publications

Affiliations

Boston University

US 2014 - 2004

Brigham and Women's Hospital

US 2013 - 2004

Boston Children's Hospital

US 2024 - 1989

National Institutes of Health

US 2005 - 2005

Albert Einstein College of Medicine

US 2015 - 2015

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Lewis B. Silverman

Publication & Citation Trends

Most Cited Works

Publications

Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen OA

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL): Post hoc analysis of adverse events of interest from AALL1931.

Abstract B025: Genome-wide study identifies novel genes associated with bone toxicities among children with acute lymphoblastic leukemia

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study OA

Oral Chemotherapy Adherence in Pediatric Acute Lymphoblastic Leukemia (ALL): A Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 16-001 OA

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) OA

Updated Results on a Multicenter Phase II Study of a Dose Intensified Pediatric Regimen in Adults with Acute Lymphoblastic Leukemia: The 06-254 DFCI ALL Consortium Trial OA

PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION OA

ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or With T315I Mutation.

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back